Brief: IBA To Receive 16 Mln Euros Funding For Cancer Therapy Project
Oct 3 (Reuters) - Ion Beam Applications SA IBAB.BR :
* IBA AND JULES BORDET INSTITUTE TO LEAD IHI PROJECT
ACCELERATE.EU
TO CREATE COMPLETE ASTATINE-211 VALUE CHAIN
* EUR 16 MILLION INITIATIVE TO ESTABLISH EU AUTONOMY IN
ALPHA
CANCER THERAPIES
* EUROPEAN COMMISSION HAS APPROVED FINANCING OF
ACCELERATE.EU
PROJECT LAUNCHING ON OCTOBER 1, 2024
Source text for Workspace: ID:nGNE1Tg9RB
Further company coverage: IBAB.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Ion Beam Applications SA
See all newsBrief: IBA Signs Contract With Government Of Assam For India's State-Run Proton Therapy Center
Brief: Iba Signs Contract For Be Efficient Sterilization Solution In Germany
Brief: IBA Says First Patient Treated In C-Flash-01 Conformalflash Clinical Trial
Brief: IBA Selected To Support The US Expansion Of Radiopharmaceutical Producer
Brief: IBA And Telix Strengthen Ties Through Agreement To Distribute ARTMS QIS